Cargando…

A microRNA gene expression signature predicts response to erlotinib in epithelial cancer cell lines and targets EMT

BACKGROUND: Treatment with epidermal growth factor receptor (EGFR) inhibitors can result in clinical response in non-small-cell lung cancer (NSCLC) and pancreatic ductal adenocarcinoma (PDAC) for some unselected patients. EGFR and KRAS mutation status, amplification of EGFR, or gene expression predi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bryant, J L, Britson, J, Balko, J M, Willian, M, Timmons, R, Frolov, A, Black, E P
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2012
Materias:	Molecular Diagnostics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3251842/ https://www.ncbi.nlm.nih.gov/pubmed/22045191 http://dx.doi.org/10.1038/bjc.2011.465

Ejemplares similares

Identification of tumour suppressive microRNA-451a in hypopharyngeal squamous cell carcinoma based on microRNA expression signature
por: Fukumoto, I, et al.
Publicado: (2014)

MicroRNA expression signature of oral squamous cell carcinoma: functional role of microRNA-26a/b in the modulation of novel cancer pathways
por: Fukumoto, I, et al.
Publicado: (2015)

Changes in circulating microRNA levels associated with prostate cancer
por: Bryant, R J, et al.
Publicado: (2012)

A urinary microRNA signature can predict the presence of bladder urothelial carcinoma in patients undergoing surveillance
por: Sapre, Nikhil, et al.
Publicado: (2016)

MicroRNA expression signature of castration-resistant prostate cancer: the microRNA-221/222 cluster functions as a tumour suppressor and disease progression marker
por: Goto, Yusuke, et al.
Publicado: (2015)

microRNA-221 and microRNA-18a identification in stool as potential biomarkers for the non-invasive diagnosis of colorectal carcinoma
por: Yau, T O, et al.
Publicado: (2014)

Identifying microRNAs regulating B7-H3 in breast cancer: the clinical impact of microRNA-29c
por: Nygren, M K, et al.
Publicado: (2014)

Epithelial-to-mesenchymal transition (EMT) induced by inflammatory priming elicits mesenchymal stromal cell-like immune-modulatory properties in cancer cells
por: Ricciardi, M, et al.
Publicado: (2015)

Identification of serum microRNA profiles in colon cancer
por: Hofsli, E, et al.
Publicado: (2013)

The functional significance of microRNA-145 in prostate cancer
por: Zaman, M S, et al.
Publicado: (2010)

Identification of circulating microRNAs as diagnostic biomarkers for use in multiple myeloma
por: Jones, C I, et al.
Publicado: (2012)

Detection of gastric cancer-associated microRNAs on microRNA microarray comparing pre- and post-operative plasma
por: Konishi, H, et al.
Publicado: (2012)

MicroRNA-143 targets DNA methyltransferases 3A in colorectal cancer
por: Ng, E K O, et al.
Publicado: (2009)

MicroRNA-206 expression levels correlate with clinical behaviour of rhabdomyosarcomas
por: Missiaglia, E, et al.
Publicado: (2010)

ING1b-inducible microRNA203 inhibits cell proliferation
por: Chen, J, et al.
Publicado: (2013)

MicroRNA-199b-5p attenuates TGF-β1-induced epithelial–mesenchymal transition in hepatocellular carcinoma
por: Zhou, Shao-jun, et al.
Publicado: (2017)

An evaluation of urinary microRNA reveals a high sensitivity for bladder cancer
por: Miah, S, et al.
Publicado: (2012)

MicroRNA-126 inhibits invasion in bladder cancer via regulation of ADAM9
por: Jia, A Y, et al.
Publicado: (2014)

Impact of cellular folate status and epidermal growth factor receptor expression on BCRP/ABCG2-mediated resistance to gefitinib and erlotinib
por: Lemos, C, et al.
Publicado: (2009)

Circulating microRNAs in plasma of patients with gastric cancers
por: Tsujiura, M, et al.
Publicado: (2010)

The small-nucleolar RNAs commonly used for microRNA normalisation correlate with tumour pathology and prognosis
por: Gee, H E, et al.
Publicado: (2011)

Serum microRNA panel as biomarkers for early diagnosis of colorectal adenocarcinoma
por: Zheng, G, et al.
Publicado: (2014)

MicroRNA-145 inhibits tumour growth and metastasis in colorectal cancer by targeting fascin-1
por: Feng, Y, et al.
Publicado: (2014)

Exosomal microRNA in serum is a novel biomarker of recurrence in human colorectal cancer
por: Matsumura, T, et al.
Publicado: (2015)

microRNA-22, downregulated in hepatocellular carcinoma and correlated with prognosis, suppresses cell proliferation and tumourigenicity
por: Zhang, J, et al.
Publicado: (2010)

MicroRNA profiling in clear cell renal cell carcinoma tissues potentially links tumorigenesis and recurrence with obesity
por: Shu, X, et al.
Publicado: (2017)

Prognostic value of microRNA expression in operable non-small cell lung cancer patients
por: Skrzypski, M, et al.
Publicado: (2014)

MicroRNA profile: a promising ancillary tool for accurate renal cell tumour diagnosis
por: Silva-Santos, R M, et al.
Publicado: (2013)

Overexpression of microRNA-223 regulates the ubiquitin ligase FBXW7 in oesophageal squamous cell carcinoma
por: Kurashige, J, et al.
Publicado: (2012)

MiR-646 inhibited cell proliferation and EMT-induced metastasis by targeting FOXK1 in gastric cancer
por: Zhang, P, et al.
Publicado: (2017)

Circulating microRNAs in plasma of patients with oesophageal squamous cell carcinoma
por: Komatsu, S, et al.
Publicado: (2011)

Enhanced stability of microRNA expression facilitates classification of FFPE tumour samples exhibiting near total mRNA degradation
por: Hall, J S, et al.
Publicado: (2012)

Acquisition of EMT phenotype in the gefitinib-resistant cells of a head and neck squamous cell carcinoma cell line through Akt/GSK-3β/snail signalling pathway
por: Maseki, S, et al.
Publicado: (2012)

Phorbol ester stimulates ethanolamine release from the metastatic basal prostate cancer cell line PC3 but not from prostate epithelial cell lines LNCaP and P4E6
por: Schmitt, J, et al.
Publicado: (2014)

MicroRNAs miR-371-3 in serum as diagnostic tools in the management of testicular germ cell tumours
por: Dieckmann, K-P, et al.
Publicado: (2012)

Circulating microRNAs as prognostic therapy biomarkers in head and neck cancer patients
por: Summerer, I, et al.
Publicado: (2015)

A five-microRNA panel in plasma was identified as potential biomarker for early detection of gastric cancer
por: Zhu, C, et al.
Publicado: (2014)

A microRNA-based prediction algorithm for diagnosis of non-small lung cell carcinoma in minimal biopsy material
por: Bediaga, N G, et al.
Publicado: (2013)

Neuroendocrine and epithelial phenotypes in small-cell lung cancer: implications for metastasis and survival in patients
por: Stovold, R, et al.
Publicado: (2013)

CBF1 is clinically prognostic and serves as a target to block cellular invasion and chemoresistance of EMT-like glioblastoma cells
por: Maciaczyk, D, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_8k3u1gjuf0ghjpiq2erob63477